Virt-Phos 250 Neutral By Virtus Pharmaceuticals Overview & Drug Interactions
Check For Interactions With Virt-Phos 250 Neutral
Supplement: Virt-Phos 250 Neutral by Virtus Pharmaceuticals
Virt-Phos 250 Neutral Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Dibasic Sodium Phosphate Anhydrous
| Ingredient Group | TBD |
|---|---|
| Category | TBD |
Monobasic Potassium Phosphate
| Ingredient Group | Phosphate Salts |
|---|---|
| Category | mineral |
Monobasic Sodium Phosphate Monohydrate
| Ingredient Group | Sodium Phosphate |
|---|---|
| Category | other |
Drugs that interact with Virt-Phos 250 Neutral by Virtus Pharmaceuticals
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Tablet(s)
|
| Maximum serving Sizes: |
2 Tablet(s)
|
| UPC/BARCODE | 369543268101 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Dibasic Sodium Phosphate Anhydrous |
852 mg
|
TBD |
--
|
| Monobasic Potassium Phosphate |
155 mg
|
Phosphate Salts |
--
|
| Monobasic Sodium Phosphate Monohydrate |
130 mg
|
Sodium Phosphate |
--
|
| Other Ingredients: |
Microcrystalline Cellulose
Croscarmellose Sodium
Stearic Acid
Magnesium Stearate
Silicon Dioxide
|
|---|
Label Statments:
| General Statements |
- 69543-268-10
- Rx
Made in USA
|
|---|---|
| FDA Statement of Identity |
- Prescription Phosphorus Dietary Supplement
|
| Formula |
- Supplying 250 mg per tablet
- Each tablet yields approximately 250 mg (25% DV for adults) of phosphorus. 298 mg sodium (13.0 mEq), and 45 mg of potassium (1.1 mEq).
- Description: Virt-Phos 250 Neutral is a prescription phosphorus dietary supplement - supplying 250 mg per tablet for use in the dietary supplement of hypophosphatemia and should be administered under the supervision of a licensed medical practitioner.
|
| Precautions |
- Allergy: Product may be exposed to tree nuts, peanuts, fish, egg, wheat, milk, soy, and shellfish during manufacture. See prescribing information.
- Precautions, contraindications, side effects: See prescribing information.
- Keep out of reach of children
- Call your licensed medical practitioner about side effects. You may report side effects by calling Vitrus at 1-888-848-3593 or FDA at 1-800-FDA-1088.
|
| Suggested/Recommended/Usage/Directions |
- Directions for use: Virt-Phos 250 Neutral should be taken with a full glass of water, with meal and at bedtime. Adults: One or two tablets four times daily; Pediatric patients over 4 years of age: One tablet four times daily; Pediatric under 4 years of age: Use only as directed by a licensed healthcare practitioner.
|
| Storage |
- Storage: Store at 20(0) to 25(0)C (68(0) to 77(0)F). Excursions permitted to 15(0) to 30(0)C (59(0) to 86(0)F). Protect from light and moisture. Dispense in a tight, light-resistant container. Notice: Contact with moisture may product surface discoloration or erosion.
|
| General |
- Rev. 06/16
|
Brand Information
See all products by this brand
| Manufactured for: | |
|---|---|
| Name | Virtus Pharmaceuticals, LLC |
| City | Tampa |
| State | FL |
| ZipCode | 33619 |
| Phone Number | 1-888-848-3593 |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.